Stephanie Paige Norris
Family · Burleson, TXNPI 1871721597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,071 of the $3,271 with a category attached, or 63.3%. 31 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 38.4% of the total. Reporting peaked in 2021 at $3,111 and has fallen 98.2% since, to $56 in 2024.
Across 175 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$313
- Novo Nordisk$202
- Esperion Therapeutics, Inc.$195
- Amgen$167
- Lilly USA, LLC$152
- plus $987 from 25 others
What the payments were for
- Consulting fees$1,20037%
- Food & beverage$2,07163%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 4 | $1,256 |
| AbbVie | 28 | $313 |
| Novo Nordisk | 18 | $202 |
| Esperion Therapeutics, Inc. | 34 | $195 |
| Amgen | 10 | $167 |
| Lilly USA, LLC | 11 | $152 |
| Pfizer | 9 | $144 |
| Currax Pharmaceuticals LLC | 13 | $120 |
| Merck | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| Amarin Pharma, Inc. | 4 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Sunovion Pharmaceuticals Inc. | 4 | $48 |
| GSK | 3 | $45 |
| Johnson & Johnson | 3 | $44 |
| Dexcom, Inc. | 2 | $41 |
| AstraZeneca | 2 | $33 |
| Alfasigma USA, Inc. | 2 | $32 |
| Kaleo, Inc. | 2 | $30 |
| Adlon Therapeutics L.p. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Antares Pharma, Inc. | 2 | $27 |
| Optinose US, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
How this compares
$3,271 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Burleson
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.